What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?
To access this article, please choose from the options below
M.B. has nothing to disclose. K.O. has nothing to disclose.
PII: S0015-0282(09)00592-5
doi:10.1016/j.fertnstert.2009.03.027
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

